Atlas FDA

INFUSE® Bone Graft

FDA premarket approval P000054/S074 · decided 2025-03-19

Approval details

PMA number
P000054
Supplement
S074
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
INFUSE® Bone Graft
Generic name
Filler, recombinant human bone morphogenetic protein, collagen scaffold, osteoinduction
Applicant
Medtronic Sofamor Danek USA, Inc.
Date received
2025-03-10
Decision date
2025-03-19
Days to decision
9 days
Decision code
OK30
Product code
MPW
Advisory committee
Orthopedic
Expedited review
No
Location
Memphis, TN
Statement
change of the current ePCD for ethylene oxide sterilization, change to the temperature and relative humidity monitoring, change to the finished good release of the collagen based medical devices

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Catalyft PL Expandable Interbody System (K253011)Medtronic Sofamor Danek USA, Inc.2026-07-17
Symmetrix™ L Spinal System (K261020)Medtronic Sofamor Danek USA, Inc.2026-07-14
OsteoCool™ RF Ablation System; OsteoCool™ 2.0 RF Ablation System (K253656)Medtronic Sofamor Danek USA, Inc.2026-06-05
CD Horizon™ ModuLeX™ Fenestrated Screw Set; CD Horizon™ ModuLeX™ Spinal System (K260216)Medtronic Sofamor Danek USA, Inc.2026-04-21
Infinity™ OCT System (K254165)Medtronic Sofamor Danek USA, Inc.2026-01-21
CD Horizon™ ModuLeX™ Spinal System (LigaMAS Head Assembly) (K253941)Medtronic Sofamor Danek USA, Inc.2026-01-07
Infinity™ OCT System (K253129)Medtronic Sofamor Danek USA, Inc.2025-10-24
CD Horizon™ Spinal System (K253335)Medtronic Sofamor Danek USA, Inc.2025-10-24